Bioventus (BVS) Raw Materials (2020 - 2026)

Bioventus (BVS) has 7 years of Raw Materials data on file, last reported at $19.3 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials fell 15.5% year-over-year to $19.3 million; the trailing twelve-month figure through Mar 2026 stood at $19.3 million (down 15.5% YoY), and the FY2025 full-year result was $21.2 million, down 3.88% from the prior year.
• Raw Materials for Q1 2026 stood at $19.3 million, down from $21.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $26.4 million in Q3 2023 and bottomed at $14.3 million in Q2 2022.
• The 5-year median for Raw Materials is $22.1 million (2024), against an average of $21.7 million.
• The widest annual swing landed in 2022, when Raw Materials soared 414.05%; it then decreased 15.5% in 2026.
• A 5-year view of Raw Materials shows it stood at $18.5 million in 2022, then increased by 14.13% to $21.1 million in 2023, then gained by 4.92% to $22.1 million in 2024, then retreated by 3.88% to $21.2 million in 2025, then declined by 9.13% to $19.3 million in 2026.
• The last three Raw Materials figures came in at $19.3 million (Q1 2026), $21.2 million (Q4 2025), and $21.9 million (Q3 2025), per Business Quant data.

Peer Comparison